Key facts
- This page summarizes Kevin Norrett's Form 4 filing for CODEXIS, INC. (CDXS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Feb 2025, 20:20.
Kevin Norrett - 05 Feb 2025 Form 4 Insider Report for CODEXIS, INC. (CDXS)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- CDXS
- Reported as of
- 05 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Feb 2025, 20:20:55 UTC
- Prior SEC filing
- 02 Jan 2024
- Next SEC filing
- 19 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Georgia Erbez, as Attorney-in-Fact for Kevin Norrett
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kevin Norrett filed Form 4 for CODEXIS, INC. (CDXS) on 07 Feb 2025.
Change
- Previous filing in this sequence was filed on 02 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDXS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +26,875
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 177,327
- Date
- 05 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDXS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +161,250
- Change %
- Price
- $0.000000
- Shares after
- 161,250
- Date
- 05 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 161,250
- Exercise price
- $4.37
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates.
Footnote F2
This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates.